Nuwellis NUWE
NASDAQ NUWE
$0.80 +0.01 (+1.52%)
At close: Sep 9, 2026 · 4:00 PM EDT

Nuwellis (NUWE) Net Income towards Common Stockholders (2011 - 2026)

Nuwellis' (NUWE) quarterly Net Income towards Common Stockholders came in at -$4.8 million in Q2 2026, up 61.54% on a YoY basis from -$3.0 million in Q2 2025, and down 6.35% quarter-over-quarter from -$4.5 million in Q1 2026.

Analysis

Nuwellis (NUWE) Net Income towards Common Stockholders (2011 - 2026) Analysis & Trends

Nuwellis (NUWE) has reported Net Income towards Common Stockholders for 16 consecutive years, with -$4.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 61.54% year-over-year to -$4.8 million; the trailing twelve-month figure through Jun 2026 stood at -$11.3 million (up 22.88% YoY), and the FY2025 full-year result was -$17.5 million, down 64.88% from the prior year.
  • Net Income towards Common Stockholders declined to -$4.8 million in Q2 2026 per NUWE's latest filing, from -$4.5 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $2.4 million in Q3 2024 and bottomed at -$12.6 million in Q2 2025.
  • Historically, Net Income towards Common Stockholders has averaged -$4.0 million across 5 years, with a median of -$4.1 million in 2022.
  • The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders jumped 552.21% in 2022, then slumped 804.0% in 2023.
  • Over 5 years, Net Income towards Common Stockholders stood at $1.1 million in 2022, then plunged by 804.0% to -$7.9 million in 2023, then surged by 81.48% to -$1.5 million in 2024, then tumbled by 64.92% to -$2.4 million in 2025, then plunged by 99.38% to -$4.8 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$4.8 million, -$4.5 million, and -$2.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 1.48 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 907.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 241.40 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 249.10 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 201.00 Mn
10 Nuwellis 140,408.95 -3.78 Mn 1.50 Mn -4.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.83 Mn
Mar 31, 2026 -4.54 Mn
Dec 31, 2025 -2.42 Mn
Sep 30, 2025 469,000.00
Jun 30, 2025 -12.55 Mn
Mar 31, 2025 -3.01 Mn
Dec 31, 2024 -1.47 Mn
Sep 30, 2024 2.36 Mn
Jun 30, 2024 -7.73 Mn
Mar 31, 2024 -3.79 Mn
Dec 31, 2023 -7.93 Mn
Sep 30, 2023 -3.37 Mn
Jun 30, 2023 -4.85 Mn
Mar 31, 2023 -6.49 Mn
Dec 31, 2022 1.13 Mn
Sep 30, 2022 -3.87 Mn
Jun 30, 2022 -4.29 Mn
Mar 31, 2022 -4.47 Mn
Dec 31, 2021 -249,000.00
Sep 30, 2021 -5.27 Mn